John Harris to Melanocytes
This is a "connection" page, showing publications John Harris has written about Melanocytes.
Connection Strength
5.748
-
Refat MA, Strassner JP, Frisoli ML, Rashighi M, Richmond J, Nada E, Saleh R, El-Hamd MA, Goldberg D, Mahmoud BH, Harris JE. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo. J Invest Dermatol. 2023 11; 143(11):2275-2282.e6.
Score: 0.757
-
Katz EL, Harris JE. Translational Research in Vitiligo. Front Immunol. 2021; 12:624517.
Score: 0.642
-
Riding RL, Harris JE. The Role of Memory CD8+ T Cells in Vitiligo. J Immunol. 2019 07 01; 203(1):11-19.
Score: 0.572
-
Richmond JM, Strassner JP, Rashighi M, Agarwal P, Garg M, Essien KI, Pell LS, Harris JE. Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo. J Invest Dermatol. 2019 04; 139(4):769-778.
Score: 0.547
-
Rashighi M, Harris JE. Vitiligo Pathogenesis and Emerging Treatments. Dermatol Clin. 2017 Apr; 35(2):257-265.
Score: 0.489
-
Strassner JP, Harris JE. Understanding mechanisms of autoimmunity through translational research in vitiligo. Curr Opin Immunol. 2016 12; 43:81-88.
Score: 0.474
-
Strassner JP, Rashighi M, Harris JE. Melanocytes in psoriasis: convicted culprit or bullied bystander? Pigment Cell Melanoma Res. 2016 May; 29(3):261-3.
Score: 0.459
-
Harris JE. IFN-? in Vitiligo, Is It the Fuel or the Fire? Acta Derm Venereol. 2015 Jul; 95(6):643-4.
Score: 0.433
-
Long TJ, Pearson TF, Harris JE. Deciphering Depigmentation: Mouse Models for Vitiligo Research. J Invest Dermatol. 2025 Sep; 145(9):2135-2146.
Score: 0.218
-
Ezzedine K, Tannous R, Pearson TF, Harris JE. Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity. J Clin Invest. 2025 Jan 16; 135(2).
Score: 0.210
-
Essien KI, Katz EL, Strassner JP, Harris JE. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo. J Invest Dermatol. 2022 12; 142(12):3158-3166.e7.
Score: 0.176
-
Frisoli ML, Harris JE. Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine. J Invest Dermatol. 2018 12; 138(12):2505-2506.
Score: 0.137
-
Richmond JM, Strassner JP, Zapata L, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Sci Transl Med. 2018 07 18; 10(450).
Score: 0.134
-
Frisoli ML, Harris JE. Vitiligo: Mechanistic insights lead to novel treatments. J Allergy Clin Immunol. 2017 Sep; 140(3):654-662.
Score: 0.125
-
Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L, Pazoki-Toroudi H, Hunter CA, Harris JE. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol. 2015 Apr; 135(4):1080-1088.
Score: 0.104
-
Harris JE. Vitiligo and alopecia areata: apples and oranges? Exp Dermatol. 2013 Dec; 22(12):785-9.
Score: 0.097
-
Seneschal J, Bae JM, Ezzedine K, Hamzavi I, Harris JE, Bellei B, Parsad D, Passeron T, van Geel N, Boniface K, Picardo M. Vitiligo. Nat Rev Dis Primers. 2025 Dec 04; 11(1):85.
Score: 0.056
-
Okamura K, Arai Y, Kawaguchi J, Tsukada S, Nakamura A, Abe Y, Fukuda K, Harris JE, Suzuki T. A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation. J Invest Dermatol. 2026 Feb; 146(2):374-382.e4.
Score: 0.054
-
Lyons AB, Ghia D, Abdallah M, Abdel-Malek Z, Esmat S, Ezzedine K, Grimes P, Harris JE, Lui H, Manga P, Mi QS, Pandya A, Parsad D, Passeron T, Picardo M, Seneschal J, Silpa-Archa N, Taieb A, Xiang F, Lim HW, Hamzavi IH. Proceeding Report of the Second Vitiligo International Symposium-November 9-10, 2018, Detroit, Michigan, USA. Pigment Cell Melanoma Res. 2020 07; 33(4):637-641.
Score: 0.037
-
Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nat Rev Dis Primers. 2015 06 04; 1:15011.
Score: 0.027